Active Protease Selection for Inhibitor Screening and Substrate-Cleavage Assays

Selecting an active recombinant protease for inhibitor screening or a substrate-cleavage assay begins with a catalytically qualified enzyme, a compatible substrate and reaction conditions that preserve the intended activity. Buyers should compare the enzyme class, species, construct, activation state, expression system, tag, documented substrate, specific activity, buffer and required cofactors before ordering. Beta LifeScience offers a dedicated recombinant protease collection and a wider enzyme portfolio, including catalog proteins with documented fluorogenic substrate-cleavage activity. Researchers can compare catalog products for initial assay development or request semi-custom and full-custom evaluation when a project requires another construct, species, tag, activation format, quantity or quality-control plan.

Request Protease Matching and a Quote

Quick Guide to Selecting an Active Recombinant Protease

The most suitable protease is not simply the correct target name. It must represent the catalytic form required by the assay and show measurable cleavage of a relevant substrate under a documented test configuration.

Featured Active Proteases for Screening and Cleavage Assays

The following catalog products illustrate different enzyme classes, constructs, tags, expression systems and fluorogenic substrates available through Beta LifeScience. Numerical activity values apply to the product-page test conditions and should be interpreted within the planned assay design.

Activity measured with one short fluorogenic peptide confirms catalytic performance in that configuration; it does not establish equal turnover of every peptide, protein or physiological substrate. Review the current product page for formulation, storage, documentation, availability and pack-size information before ordering. Need help selecting a protease and substrate configuration? Share the target, species, assay platform, substrate, required quantity and screening objective for product matching and quotation review.

Request Active Protease Matching

How to Choose Proteases for Inhibitor Screening

Confirm the catalytic class

Proteases are commonly grouped as serine, cysteine, aspartic, metallo- and threonine proteases. The catalytic mechanism determines important assay variables. Cysteine proteases may require a reducing environment; metalloproteases may depend on a metal ion; serine proteases can be sensitive to serine-reactive compounds; and aspartic proteases often favor acidic conditions. This classification also guides control-inhibitor selection. A broad-spectrum inhibitor may verify that signal depends on proteolysis, while a target-relevant inhibitor can support assay performance. For selectivity studies, include related proteases that could cleave the same substrate.

Verify the active form and construct boundaries

Many proteases are synthesized as inactive zymogens and become active after propeptide removal or another processing step. Others contain regulatory, transmembrane or accessory regions that may be absent from a soluble recombinant construct. Confirm whether the catalog protein represents a precursor, mature enzyme, catalytic domain or activated preparation. Construct design should follow the experimental question. A catalytic domain may work well with a short peptide substrate, while cleavage of a folded protein substrate may depend on exosites or domains outside the catalytic core. Mutations, terminal tags and artificial activation procedures can also affect activity.

Match the expression system to the protease

Mammalian expression can support secretion, disulfide formation, glycosylation and processing of complex human proteases. Bacterial expression may provide an efficient route for selected catalytic domains, viral proteases or proteins that do not require mammalian post-translational modifications. Insect and yeast systems provide additional options for targets requiring eukaryotic folding with different production characteristics. The host should be selected according to the target rather than treated as a universal quality ranking. Compare the expression system with the enzyme's activation requirements, solubility, substrate recognition and intended assay.

Review the tag and immobilization strategy

A His tag can support purification or capture, while an AviTag allows site-specific biotinylation and streptavidin-based immobilization. Tag orientation matters when a terminus lies near a catalytic, regulatory or substrate-binding region. For a solution-phase cleavage assay, immobilization may be unnecessary. For capture, interaction or wash-based workflows, a tagged format can simplify orientation. When comparing wild-type and mutant enzymes, align the tag and construct boundaries to reduce configuration-related differences.

Match the Substrate to the Screening Objective

Fluorogenic peptide substrates

AMC-based and related fluorogenic peptides provide sensitive, continuous measurement of substrate cleavage. Protease-mediated release of the fluorophore generates increasing signal, allowing initial velocity, specific activity and inhibitor-response measurements. Their compact format is well suited to plate-based screening. However, short peptides report cleavage of a defined sequence rather than every aspect of physiological substrate recognition. A candidate inhibitor identified with a peptide substrate may require confirmation with an orthogonal or more biologically relevant substrate.

FRET substrates

FRET peptides contain a fluorophore–quencher pair. Cleavage separates the pair and increases fluorescence, enabling sequence-specific designs spanning the scissile bond. Check compound fluorescence and quenching because optical interference can affect apparent inhibition.

Chromogenic substrates

Chromogenic peptides release a colored product measurable by absorbance. They offer straightforward detection, although sensitivity depends on enzyme activity, substrate and path length.

Protein and physiological substrates

Protein substrates can test cleavage-site accessibility and extended recognition. SDS-PAGE, Western blotting, ELISA or mass spectrometry can provide confirmation after primary peptide screening.

Establish Assay Conditions Before Screening Compounds

Protease activity depends on pH, salt, temperature, cofactors, reducing agents, detergents and solvent. Titrate enzyme and substrate to identify a linear reaction window with a practical signal-to-background ratio and limited substrate depletion.

The NIH Assay Guidance Manual recommends developing enzymatic assays with attention to enzyme concentration, substrate concentration, reaction linearity and control performance. For mechanism-of-action work, substrate concentrations spanning the apparent Km and consistent DMSO levels can help distinguish inhibition behavior (Mechanism of Action Assays for Enzymes).

An assay-development plate should normally include:

• enzyme plus substrate as the maximum-activity control;
• substrate without enzyme as the minimum-signal control;
• enzyme without substrate to identify protein or buffer background;
• a known inhibitor where available;
• a vehicle-matched control with constant DMSO concentration;
• test compound without enzyme to detect fluorescence, absorbance or quenching interference; and
• a time course to confirm the selected linear measurement window.

Interpret IC50 and Specific Activity Carefully

Specific activity describes catalytic performance within a stated substrate and buffer configuration; it is not universal across assays. IC50 is also assay-dependent and can shift with enzyme, substrate, incubation time and inhibition mechanism. Use enough inhibitor concentrations to define both response plateaus. Confirm hits, examine solubility and optical interference, and consider whether Ki, reversibility, time dependence or tight-binding analysis is required.

Choose a Catalog, Semi-Custom or Custom Protease Route

Sequence changes, activation strategies and custom substrate-cleavage validation depend on target feasibility and the agreed project scope. Submit the assay objective with the protein specification so production and activity testing can be evaluated together.

Why Source Active Proteases from Beta LifeScience?

Beta LifeScience combines a broad recombinant protease catalog with semi-custom and full-custom production routes. Researchers can begin with products that have documented substrate-cleavage activity and request technical evaluation when the project needs another species, sequence, tag, activation state, formulation, quantity or activity assay.

Depending on target feasibility and project scope, available options may include:

• bacterial, yeast, insect or mammalian expression evaluation;
• construct, catalytic-domain and tag planning;
• purification and formulation aligned with enzyme stability;
• purity, identity, endotoxin and activity testing;
• alternate packaging or bulk quantity evaluation; and
• coordinated wild-type, mutant, ortholog or selectivity panels.

Product-specific documentation should guide catalog selection. For a custom project, define acceptance criteria before production so the quotation distinguishes essential deliverables from optional assay development.

Information to Include in a Protease Quote Request

Provide a quote-ready specification:

1. Protease name, species, accession number and sequence
2. Required active form, activation method and construct boundaries
3. Preferred expression system and tag configuration
4. Intended substrate and cleavage site
5. Assay format, detection method and plate scale
6. Required activity, purity, endotoxin and aggregation criteria
7. Buffer, cofactor, reducing-agent and detergent requirements
8. Quantity, concentration, aliquot size and delivery schedule
9. Control proteases, mutants or orthologs needed for selectivity
10. Required documentation and timeline

Include previous expression, activation or assay data where available. Submitting the complete target panel and essential QC requirements together supports a more informative technical review and quotation.

FAQs

What makes a recombinant protease suitable for inhibitor screening?

It should be catalytically active in a documented substrate-cleavage assay and supplied in a construct and buffer compatible with the planned screen. Reconfirm activity under the final assay conditions before testing compounds.

Can I compare specific activity values from different proteases directly?

Only with caution. Substrate sequence, buffer, temperature, enzyme preparation and calculation method can differ. Treat each value as configuration-specific unless the proteases were tested under aligned conditions.

Is a fluorogenic peptide enough to validate inhibitor activity?

It is effective for primary screening and kinetics. Confirm promising compounds with interference controls and, where relevant, an orthogonal or protein-substrate assay.

Do I need an active protease or a zymogen?

Choose an active preparation for direct cleavage screening. Select a zymogen when the study specifically examines activation, processing or an upstream pathway, and include the activation system in assay planning.

Can biotinylated KLK5 be used in a cleavage assay?

Its product page documents Boc-VPR-AMC cleavage and a streptavidin-capture ELISA. Confirm whether biotinylation and the supplied buffer suit the intended solution-phase or capture-based configuration.

Can Beta LifeScience produce a custom protease mutant or panel?

Mutants, orthologs, domains and coordinated panels can be submitted for technical evaluation. Feasibility, activation strategy, activity testing, quantity and documentation are defined during quotation review.

Compare Active Proteases for Your Screening Workflow

Select an active recombinant protease by catalytic class, species, construct, activation state, expression system, tag, substrate and documented activity. Begin with a catalog protein when its tested configuration fits the assay; request semi-custom or full-custom evaluation for alternative formats, mutants, panels, quantities or project-specific activity testing.

• Compare Recombinant Proteases
• Request Protease Product Matching and a Quote

Alternatively, email inquiry@betalifesci.com with the target, sequence, substrate, assay format, required quantity and quality-control specifications.